Skip to main content
Livermore
Livermore
ZHEN

Creative Planning

SEC CIK
0001540235
Latest filing
Aug 13, 2026

LCTX holding history

Lineage Cell Therapeutics, Inc. in every 13F filed by Creative Planning, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LCTX overviewAll 13F holders of LCTXFull Q2 2026 holdings

Shares (Q2 2026)
13,600
Value
$17.8K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of LCTX by Creative Planning, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202613,600$17.8K<0.1%−85−0.6%ReducedHolders
Q1 202613,685$21.6K<0.1%−4,522−24.8%ReducedHolders
Q4 202518,207$30.4K<0.1%+439+2.5%AddedHolders
Q3 202517,768$30.0K<0.1%+3,722+26.5%AddedHolders
Q2 202514,046$12.7K<0.1%+1,485+11.8%AddedHolders
Q1 202512,561$5.67K<0.1%−11,611−48.0%ReducedHolders
Q4 202424,172$12.1K<0.1%00.0%UnchangedHolders
Q3 202424,172$21.9K<0.1%00.0%UnchangedHolders
Q2 202424,172$24.1K<0.1%−1,929−7.4%ReducedHolders
Q1 202426,101$38.6K<0.1%00.0%UnchangedHolders
Q4 202326,101$28.4K<0.1%−1,942−6.9%ReducedHolders
Q3 202328,043$33.1K<0.1%−2,848−9.2%ReducedHolders
Q2 202330,891$43.6K<0.1%00.0%UnchangedHolders
Q1 202330,891$46.3K<0.1%+4,600+17.5%AddedHolders
Q4 202226,291$30.8K<0.1%−77−0.3%ReducedHolders
Q3 202226,368$30.0K<0.1%+66+0.3%AddedHolders
Q2 202226,302$42.0K<0.1%+721+2.8%AddedHolders
Q1 202225,581$39.0K<0.1%+2,000+8.5%AddedHolders
Q4 202123,581$58.0K<0.1%−1,977−7.7%ReducedHolders
Q3 202125,558$64.0K<0.1%+558+2.2%AddedHolders
Q2 202125,000$71.0K<0.1%−91,453−78.5%ReducedHolders
Q1 2021116,453$274.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.